JP2017517533A5 - - Google Patents

Download PDF

Info

Publication number
JP2017517533A5
JP2017517533A5 JP2016572258A JP2016572258A JP2017517533A5 JP 2017517533 A5 JP2017517533 A5 JP 2017517533A5 JP 2016572258 A JP2016572258 A JP 2016572258A JP 2016572258 A JP2016572258 A JP 2016572258A JP 2017517533 A5 JP2017517533 A5 JP 2017517533A5
Authority
JP
Japan
Prior art keywords
composition
phosphatidylethanolamine
mol
peg
phosphatidylcholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572258A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517533A (ja
JP6594909B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/035681 external-priority patent/WO2015192093A1/en
Publication of JP2017517533A publication Critical patent/JP2017517533A/ja
Publication of JP2017517533A5 publication Critical patent/JP2017517533A5/ja
Application granted granted Critical
Publication of JP6594909B2 publication Critical patent/JP6594909B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572258A 2014-06-12 2015-06-12 リン脂質組成物、その凍結乾燥方法および凍結乾燥物 Active JP6594909B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462011469P 2014-06-12 2014-06-12
US62/011,469 2014-06-12
PCT/US2015/035681 WO2015192093A1 (en) 2014-06-12 2015-06-12 Phospholipid composition and microbubbles and emulsions formed using same

Publications (3)

Publication Number Publication Date
JP2017517533A JP2017517533A (ja) 2017-06-29
JP2017517533A5 true JP2017517533A5 (enExample) 2018-07-12
JP6594909B2 JP6594909B2 (ja) 2019-10-23

Family

ID=54834464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572258A Active JP6594909B2 (ja) 2014-06-12 2015-06-12 リン脂質組成物、その凍結乾燥方法および凍結乾燥物

Country Status (8)

Country Link
US (3) US9801959B2 (enExample)
EP (1) EP3154591B1 (enExample)
JP (1) JP6594909B2 (enExample)
KR (1) KR102379534B1 (enExample)
CN (1) CN107106692B (enExample)
AU (1) AU2015274259B2 (enExample)
CA (1) CA2951922C (enExample)
WO (1) WO2015192093A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL296875A (en) 2014-12-31 2022-12-01 Lantheus Medical Imaging Inc Fat-wrapped gas microsphere preparations and related methods
IL260206B2 (en) * 2015-12-21 2023-04-01 Nuvox Pharma Llc Preparations containing a nanoemulsion of fluorocarbons and methods for their preparation
US20190117800A1 (en) * 2016-04-19 2019-04-25 Microvascuar Therapeutics Llc Systems and methods for filling vials with gases
CN109641068B (zh) 2016-05-04 2022-09-30 蓝瑟斯医学影像公司 用于制备超声波造影剂的方法及装置
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
EP3530266A1 (en) * 2018-02-27 2019-08-28 LipoCoat B.V. A lipid-based coating composition, and an object having a lipid-based coating
WO2019191557A1 (en) * 2018-03-29 2019-10-03 Case Wester Reserve University Stabilized nanobubbles and microbubbles for diagnostic and therapeutic applications
CN116173238A (zh) * 2018-03-29 2023-05-30 微脉管治疗有限公司 用于检测和治疗阿尔茨海默病的组合物及方法
US11717570B2 (en) 2019-05-15 2023-08-08 Bracco Suisse Sa Gas-filled microvesicles
US20200360289A1 (en) 2019-05-15 2020-11-19 Bracco Suisse Sa Freeze-dried product and gas-filled microvesicles suspension
US20220387460A1 (en) * 2019-11-11 2022-12-08 Washington University Liposome compositions and methods of treatment targeted to tumor endothelium
CN111729094B (zh) * 2020-07-23 2021-07-02 四川大学华西医院 类磷脂两亲性嵌段共聚物基超声造影剂及其制备方法
NL2027237B1 (en) * 2020-12-27 2022-07-21 Solstice Pharmaceuticals B V Process for controlled manufacturing of mono-disperse microbubbles
CN116897055A (zh) * 2020-12-27 2023-10-17 索尔斯蒂斯制药有限公司 用于混合旨在用于体内使用的磷脂组合物的筒
US20240299653A1 (en) * 2020-12-27 2024-09-12 Solstice Pharmaceuticals B.V. A Cartridge for Mixing a Liquid Intended for Intracorporeal Use
JP2025506154A (ja) * 2022-02-09 2025-03-07 ランセウス メディカル イメージング， インコーポレイテッド ガスナノ／マイクロバブル組成物およびその使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
IL122249A0 (en) * 1995-06-07 1998-04-05 Alliance Pharmceutical Corp Fluorocarbon pharmaceutical formulations and their preparation
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE69737915T2 (de) * 1996-09-11 2008-03-13 Bristol-Myers Squibb Medical Imaging, Inc. Verfahren zur diagnostischen Bilderzeugung der Nierenregion unter Verwendung eines Kontrastmittels und eines Vasodilators
US6572840B1 (en) * 1999-07-28 2003-06-03 Bristol-Myers Squibb Pharma Company Stable microbubbles comprised of a perfluoropropane encapsulated lipid moiety for use as an ultrasound contrast agent
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
US20050025710A1 (en) * 2003-07-29 2005-02-03 Michel Schneider Reconstitutable formulation and aqueous suspension of gas-filled microvesicles for diagnostic imaging
CN101389273B (zh) * 2004-08-05 2012-09-05 贝勒研究院 基因或药物递送系统
EP2253308A1 (en) * 2009-05-22 2010-11-24 Ludwig-Maximilians-Universität München Pharmaceutical composition comprising microbubbles for targeted tumor therapy
US10279053B2 (en) * 2011-07-19 2019-05-07 Nuvox Pharma Llc Microbubble compositions, method of making same, and method using same

Similar Documents

Publication Publication Date Title
JP2017517533A5 (enExample)
JP2022549253A (ja) 治療薬の細胞内送達のためのカーボネート含有脂質化合物及び組成物
JP2013526545A5 (enExample)
JP2015515992A5 (enExample)
KR102751412B1 (ko) 생물학적 활성 분자의 전달을 위한 융합성 화합물
CA2914205A1 (en) Targeted crosslinked multilamellar liposomes
RU2015103538A (ru) Способы лечения артрита
JP2015509505A5 (enExample)
JP6705933B2 (ja) リポソーム組成物およびその製造方法
JP7829485B2 (ja) がんの処置において有用なＴｏｌｌ様受容体（「ＴＬＲ」）アゴニストプロドラッグを含有する製剤化および／または共製剤化リポソーム組成物ならびにその方法
RU2020137384A (ru) Средство для лечения опухоли и набор, содержащий липосомальную композицию гемцитабина
Zhang et al. Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model
JP2018527335A5 (enExample)
US20240016940A1 (en) Long-acting and long-circulating delivery vehicles
Porte et al. A molecular view of lipid nanoparticles: insights into their morphology and structural plasticity
WO2007088952A1 (ja) 抗腫瘍活性物質のリポソーム製剤
JP5914418B2 (ja) 脂質粒子、核酸送達キャリア、核酸送達キャリア製造用組成物、脂質粒子の製造方法及び遺伝子導入方法
AU2007229160A1 (en) Lipid based drug delivery systems comprising phospholipase A2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
RU2015117412A (ru) Улучшенный способ получения инкапсулированного в липосомы винкристина для терапевтического применения
JP5817053B2 (ja) 腫瘍特異性を有するリポソーム
CN114746124A (zh) 包含活性剂沉淀物的递送系统复合物和使用方法
HRP20230985T1 (hr) Farmaceutske formulacije pegiliranih liposoma i faktora koagulacije krvi
JP2020079303A (ja) リポソーム及びリポソーム組成物
JP6404034B2 (ja) 核酸を内封してなる中性又はアニオン性リポソーム及びその製造方法。
JP2011172519A (ja) 機能性ポリペプチド及び当該ポリペプチドで修飾された脂質膜構造体